arGEN-X awarded €1.5 million IWT grant to advance the application of NHance Fc modifications in therapeutic antibodies

20-May-2015 - arGEN-X N.V. announced that it has received a € 1.5 million grant from the Institute for the Promotion of Innovation by Sciences and Technology in Flanders (IWT). This grant will be used to advance and commercialize the application of the NHance® Fc modifications in therapeutic antibodies.“We ...

BioCartis receives € 1,7M IWT grant for improved disease diagnosis

30-Jun-2014 - Biocartis announced it received a grant of € 1.7M from the Flemish Government to further enhance the capabilities of its flagship platform Idylla™. With this grant the Flemish Agency for Innovation by Science andTechnology (IWT) affirms its belief in Biocartis’ cutting edge R&D. Biocartis will ...

Multiplicom receives €200,000 grant for novel non-invasive pre-natal test

IWT grant to support development of early aneuploidy detection during pregnancy

13-Jun-2012 - Multiplicom, a molecular diagnostics company specializing in the design, development, production and commercialization of molecular genetic tests based on massively parallel sequencing, announced that it has been awarded a €200,000 grant from the Flemish agency for Innovation by Science and ...

Athersys Awarded $3.6 Million in Grant Funding For Stem Cell Product Development

Funding supports advancement for treatment of neurological and cardiovascular conditions & advanced manufacturing platform

03-Feb-2012 - Athersys, Inc. announced grant funding aggregating $3.6 million to further advance its MultiStem® product programs and cell therapy platform. Specifically, Athersys was awarded a SBIR Fast-Track grant of up to $1.9 million from the National Institute of Neurological Disorders and Stroke (NINDS) ...

IWT helps to accelerate reMYND’s Diabetes program with a grant of 1.48 million EUR for 2011-2012

29-Jun-2011 - reMYND NV announced that it has received a grant of 1.48 million EUR from IWT, the Flemish agency for Innovation by Science and Technology, to accelerate its Diabetes program. reMYND’s Drug Discovery & Development focuses on the development of disease-modifying drugs for patients suffering from ...

Ablynx secures €1.5 million in grants

06-Jul-2010 - Ablynx announced that it has been awarded a grant worth €1.1 million by the Flemish agency for Innovation by Science and Technology (IWT) and a second grant worth €0.4 million from the Portuguese government, as part of a consortium. The IWT grant allows Ablynx to accelerate its pre-clinical ...

Ablynx receives €1.2 million grant to further advance its anti-IL-6R programme, ALX-0061

23-Feb-2010 - Ablynx announced that it has been awarded a grant worth €1.2 million by the Flemish agency for Innovation by Science and Technology (IWT). The grant supports Ablynx in accelerating the development of its Nanobody-based programme, ALX-0061, into clinical development for the treatment of ...

Pronota awarded EUR 1.4 million grant to validate and develop novel cardiovascular biomarkers

14-Jan-2010 - Pronota NV has announced that it has been awarded an EUR 1.4 million grant from IWT (the Institute for the Promotion of Innovation by Science and Technology in Flanders) to further validate and develop novel biomarkers for the management of heart failure. The grant will be used to validate and ...